The vote took place last week.
“Clinicians and healthcare leaders from around the state have a clear message — this ballot measure is the wrong prescription for Massachusetts,” Lynn Nicholas, CEO of the hospital association, said, according to the report.
According to the International Business Times, critics of the proposed measure have questioned the science and safety studies surrounding pot, saying they have not been widely performed enough to definitively say the drug is safe. On the other hand, supporters of the measure have noted that attempts to study the drug have been repeatedly blocked by the federal government, and that legalization could potentially take money away from a powerful pharmaceutical industry.
State lawmakers have said there are consequences if the measure passes, including how children could have easy access to the drug if family members kept it in the house, according to the report.
Medical marijuana is already legal in Massachusetts.
More articles on legal and regulatory issues:
California will allow medically assisted suicide starting in June: 6 things to know
Republicans challenge legality of ACA reinsurance program: 5 things to know
8 latest healthcare industry lawsuits, settlements
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
